A Professional Standard for Informed Consent for Stem Cell Therapies.
American Medical Association
MetadataShow full item record
Sugarman, J., Barker, R., & Charo, R. A. (2019). A Professional Standard for Informed Consent for Stem Cell Therapies.. JAMA https://doi.org/10.1001/jama.2019.11290
In November 2018, the US Food & Drug Administration (FDA) issued a press release that stated: “The potential health benefits of regenerative medicine have spurred major progress in stem-cell biology over the past several decades. But we continue to see bad actors exploit the scientific promise of this field to mislead vulnerable patients into believing they’re being given safe, effective treatments; when instead these stem cell producers are leveraging the field’s hype to push unapproved, unproven, illegal, and potentially unsafe products."
Embargo Lift Date
External DOI: https://doi.org/10.1001/jama.2019.11290
This record's URL: https://www.repository.cam.ac.uk/handle/1810/294731
All rights reserved